Genome-wide analysis of estrogen receptor binding sites

Nature Genetics

Volumn 38, Issue 11, 2006, Pages 1289-1297

  Carroll, Jason S ^a   Meyer, Clifford A ^a,b   Song, Jun ^a,b   Li, Wei ^a,b   Geistlinger, Timothy R ^a   Eeckhoute, Jérôme ^a   Brodsky, Alexander S ^c   Keeton, Erika Krasnickas ^a   Fertuck, Kirsten C ^a   Hall, Giles F ^a   Wang, Qianben ^a   Bekiranov, Stefan ^d,e   Sementchenko, Victor ^d   Fox, Edward A ^a   Silver, Pamela A ^a   Gingeras, Thomas R ^d   Liu, X Shirley ^a,b   Brown, Myles ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BROWN UNIVERSITY   (United States)

^d Thermo Fisher Scientific   (United States)

^e UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; RNA POLYMERASE II;

ARTICLE; BINDING SITE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE MAPPING; GENE REPRESSION; GENE TARGETING; GENOME ANALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; BREAST NEOPLASMS; CELLS, CULTURED; CHROMOSOME MAPPING; CONSERVED SEQUENCE; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; MICROARRAY ANALYSIS; NUCLEAR PROTEINS; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSCRIPTION INITIATION SITE;

EID: 33750442923     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1901     Document Type: Article

References (49)

1. Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869-10874 (2001).
2. van 't Veer, L.J. et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536 (2002).
3. van de Vijver, M.J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999-2009 (2002).
4. Wang, Y. et al. Gene-expression profiles to predict distant metastasis of lymph-nodenegative primary breast cancer. Lancet 365, 671-679 (2005).
5. Perou, C.M. et al. Molecular portraits of human breast tumours. Nature 406, 747-752 (2000).
6. Shang, Y., Hu, X., DiRenzo, J., Lazar, M.A. & Brown, M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103, 843-852 (2000).
7. Shang, Y. & Brown, M. Molecular determinants for the tissue specificity of SERMs. Science 295, 2465-2468 (2002).
8. Metivier, R. et al. Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115, 751-763 (2003).
9. Laganiere, J. et al. Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. USA 102, 11651-11656 (2005).
10. Cheng, A.S. et al. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol. Cell 21, 393-404 (2006).
11. Carroll, J.S. et al. Chromosome-wide mapping of estrogen receptor binding reveals long -range regulation requiring the forkhead protein FoxA1. Cell 122, 33-43 (2005).
12. Cheng, J. et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 308, 1149-1154 (2005).
13. Brodsky, A.S. et al. Genomic mapping of RNA polymerase II reveals sites of cotranscriptional regulation in human cells. Genome Biol. 6, R64 (2005).
14. Johnson, W.E. et al. MAT: Model-based analysis of tiling-arrays for ChIP-chip. Proc. Natl. Acad. Sci. USA (in the press) (2006).
15. Kent, W.J. BLAT-the BLAST-like alignment tool. Genome Res. 12, 656-664 (2002).
16. Kim, T.H. et al. A high-resolution map of active promoters in the human genome. Nature 436, 876-880 (2005).
17. Klinge, C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 29, 2905-2919 (2001).
18. O'Lone, R., Frith, M.C., Karlsson, E.K. & Hansen, U. Genomic targets of nuclear estrogen receptors. Mol. Endocrinol. 18, 1859-1875 (2004).
19. Frasor, J. et al. Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144, 4562-4574 (2003).
20. Nishidate, T. et al. Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int. J. Oncol. 25, 797-819 (2004).
21. Kalaitzidis, D. & Gilmore, T.D. Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol. Metab. 16, 46-52 (2005).
22. Lazennec, G., Huignard, H., Valotaire, Y. & Kern, L. Characterization of the transcription start point of the trout estrogen receptor-encoding gene: evidence for alternative splicing in the 5′ untranslated region. Gene 166, 243-247 (1995).
23. Lydon, J.P. et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9, 2266-2278 (1995).
24. Ghosh, M.G., Thompson, D.A. & Weigel, R.J. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res. 60, 6367-6375 (2000).
25. Hoch, R.V., Thompson, D.A., Baker, R.J. & Weigel, R.J. GATA-3 is expressed in association with estrogen receptor in breast cancer. Int. J. Cancer 84, 122-128 (1999).
26. Dubik, D. & Shiu, R.P. Mechanism of estrogen activation of c-myc oncogene expression. Oncogene 7, 1587-1594 (1992).
27. Prefontaine, G.G. et al. Selective binding of steroid hormone receptors to octamer transcription factors determines transcriptional synergism at the mouse mammary tumor virus promoter. J. Biol. Chem. 274, 26713-26719 (1999).
28. Cicatiello, L. et al. Estrogens and progesterone promote persistent CCND1 gene activation during G1 by inducing transcriptional derepression via c-Jun/c-Fos/estrogen receptor (progesterone receptor) complex assembly to a distal regulatory element and recruitment of cyclin D1 to its own gene promoter. Mol. Cell. Biol. 24, 7260-7274 (2004).
29. Boruk, M., Savory, J.G. & Hache, R.J. AF-2-dependent potentiation of CCAAT enhancer binding protein beta-mediated transcriptional activation by glucocorticoid receptor. Mol. Endocrinol. 12, 1749-1763 (1998).
30. Umayahara, Y. et al. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269, 16433-16442 (1994).
31. Kushner, P.J. et al. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 74, 311-317 (2000).
32. Cirillo, L.A. et al. Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome. EMBO J. 17, 244-254 (1998).
33. Cirillo, L.A. et al. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 9, 279-289 (2002).
34. Lee, C.H., Chinpaisal, C. & Wei, L.N. Cloning and characterization of mouse RIP140, a corepressor for nuclear orphan receptor TR2. Mol. Cell. Biol. 18, 6745-6755 (1998).
35. Teyssier, C., Belguise, K., Galtier, F., Cavailles, V. & Chalbos, D. Receptor-interacting protein 140 binds c-Jun and inhibits estradiol-induced activator protein-1 activity by reversing glucocorticoid receptor-interacting protein 1 effect. Mol. Endocrinol. 17, 287-299 (2003).
36. Cawley, S. et al. Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 116, 499-509 (2004).
37. Spilianakis, C.G., Lalioti, M.D., Town, T., Lee, G.R. & Flavell, R.A. Interchromosomal associations between alternatively expressed loci. Nature 435, 637-645 (2005).
38. van Steensel, B. Mapping of genetic and epigenetic regulatory networks using microarrays. Nat. Genet. 37(Suppl.), S18-S24 (2005).
39. Webb, P. et al. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol. Endocrinol. 13, 1672-1685 (1999).
40. Ren, B. et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16, 245-256 (2002).
41. Kapranov, P. et al. Large-scale transcriptional activity in chromosomes 21 and 22. Science 296, 916-919 (2002).
42. Irizarry, R.A. et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15 (2003).
43. Dai, M. et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175 (2005).
44. Siepel, A. et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 15, 1034-1050 (2005).
45. Matys, V. et al. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31, 374-378 (2003).
46. Sandelin, A., Alkema, W., Engstrom, P., Wasserman, W.W. & Lenhard, B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91-D94 (2004).
47. Song, J.S. & Liu, X.S. LeitMotif: de novo motif discovery for ChIP-Chip in mammalian genomes. In Preparation.
48. Liu, X.S., Brutlag, D.L. & Liu, J.S. An algorithm for finding protein-DNA binding sites with applications to chromatin-immunoprecipitation microarray experiments. Nat. Biotechnol. 20, 835-839 (2002).
49. Darroch, J., Lauritzen, S. & Speed, T. Markov fields and log-linear interaction models for contingency tables. Ann. Statist. 8, 522-539 (1980).